Sejal Parekh

ORCID: 0000-0002-3135-7710
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Patient Satisfaction in Healthcare
  • Antibiotic Use and Resistance
  • Nursing Roles and Practices
  • Clostridium difficile and Clostridium perfringens research
  • Inflammatory mediators and NSAID effects
  • Urinary Bladder and Prostate Research
  • Urinary Tract Infections Management
  • Venous Thromboembolism Diagnosis and Management
  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • Atrial Fibrillation Management and Outcomes
  • Drug-Induced Hepatotoxicity and Protection
  • Microscopic Colitis
  • Pelvic floor disorders treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Primary Care and Health Outcomes

NHS England
2023-2024

Community Care
2023

Personalis (United States)
2023

Middlesex University
2015

Antimicrobial Stewardship (AMS) requires effective teamwork between healthcare professionals, with patients receiving consistent messages from all professionals on the appropriate antimicrobial use. Patient education may reduce patients’ expectations to receive antibiotics for self-limiting conditions and pressure primary care clinicians prescribe antibiotics. The TARGET Antibiotic Checklist is part of national AMS resources aims support interaction community pharmacy teams prescribed...

10.3390/antibiotics12040647 article EN cc-by Antibiotics 2023-03-24

Since 2020, England’s Pharmacy Quality Scheme (PQS) has incentivised increased antimicrobial stewardship (AMS) activities in community pharmacy. In 2020/21, this included the requirement for staff to complete an AMS e-Learning module, pledge be Antibiotic Guardian and develop Action plan. To build embed these initiatives, 2021/22, PQS required use of TARGET Checklist (an tool when patients present with a prescription antibiotics support conducting recording series safety appropriateness...

10.3390/antibiotics12040793 article EN cc-by Antibiotics 2023-04-21

Introduction Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for their analgesic and action, but the gastrointestinal (GI) adverse effects a known cause of preventable harm. A medication safety audit was incentivised community pharmacies in England 2 successive years as part Pharmacy Quality Scheme (PQS) to address GI NSAIDs. Aims To evaluate pharmacy’s contributions NSAID determine any change between 1 (2018–2019) (2019–2020). Method Patients aged 65 or over prescribed an...

10.1136/bmjoq-2022-002002 article EN cc-by-nc BMJ Open Quality 2023-01-01

Most urinary tract infections (UTIs) are self-limiting and frequently present in primary care; it is common for patients to seek symptom relief. The TARGET Treating Your Infection (TYI) leaflet was used respond UTI symptoms women under 65 years presenting community pharmacies. widespread use of these leaflets incentivised as part NHS England’s Pharmacy Quality Scheme (PQS) 2022–23, between October 2022 March 2023. TYI aimed support appropriate antibiotic antimicrobial stewardship (AMS) well...

10.3390/antibiotics12091383 article EN cc-by Antibiotics 2023-08-30

Anticoagulants are life-saving medicines that can prevent strokes for patients diagnosed with atrial fibrillation (AF) as well treating venous thromboembolism (VTE), but when used incorrectly, they frequently associated patient harm.

10.3390/pharmacy12050134 article EN cc-by Pharmacy 2024-08-29

An estimated 1.27 million deaths globally were caused by antibiotic-resistant infections in 2019. Outcome 2 of the UK national action plan to combat antimicrobial resistance is improved public engagement and education with a specific measurable target. To evaluate compare years use TARGET antibiotic checklist England's community pharmacies via Pharmacy Quality Scheme (PQS). The was incentivized PQS for 2021-22 2023-24 patients presenting prescription pharmacy during 4 week period each year....

10.1093/jacamr/dlaf018 article EN cc-by JAC-Antimicrobial Resistance 2024-12-26

Previous evidence suggested a significant variation in the testing algorithms used across United Kingdom for diagnosis of Clostridium difficile infection (CDI) and new national guidelines were issued 2012. The main aim this paper was to explore if such reporting is still present, compare management CDI cases, investigate there any antibiotic policies among different hospitals. Using London hospitals as sample, results show that wide methods used, making comparisons difficult. It likely...

10.1177/1757177415580467 article EN cc-by-nc Journal of Infection Prevention 2015-04-14

NHS England designs and administers improvement assurance schemes that include elements to incentivize prudent use of antimicrobials, optimise patient outcomes, minimise avoidable exposure reduce selection pressure for antimicrobial resistance (AMR). These the System Oversight Framework, Pharmacy Quality Scheme community pharmacies, Standard Contract, Commissioning Innovation (CQUIN) framework. This report describes implemented from 2021 2022, it reports scheme performance commissioners...

10.3390/msf2022015016 article EN cc-by 2023-03-28

A summary of key national primary and secondary care antimicrobial stewardship interventions led by the UK Health Security Agency (UKHSA) are highlighted. This includes development implementation TARGET Antibiotics Toolkit resources in community pharmacy General Practice a intravenous-to-oral switch (IVOS) criteria for use care.

10.3390/msf2022015014 article EN cc-by 2023-03-28
Coming Soon ...